Aphea.Bio
PrivateLast Round
Grant
Sep 16, 2025
Total Funding Raised
$131.93M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aphea.Bio operates in Healthcare & Life Sciences and is based in Belgium. Its latest recorded funding round was a Grant round in November 2024.
Aphea.Bio is an agricultural biotechnology company that develops microorganism-based biostimulants and biocontrol products to enhance crop yields and health while promoting sustainable agricultural practices.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aphea.Bio Comparables
Compare Aphea.Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioConsortia, Inc. | 83% | |
| Fyteko | 83% | |
| Evologic Technologies | 79% |
For institutional investors. Book with your work email.
Aphea.Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 16, 2025 | ||||
| Grant | Nov 4, 2024 | ||||
| Series C | Jul 11, 2023 | ||||
| Series B | Apr 14, 2021 | ||||
| Series B | Nov 20, 2020 | ||||
Series A | Jun 26, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aphea.Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series C |
| Sopartec | Series B, Series A |
| KU Leuven Research & Development (LRD) | Series B |
| Astanor Ventures | Series C, Series B |
| Korys | Series C |
| KU Leuven | Series A |
| V-Bio Ventures | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 147% MoM.
- Sep 16, 2025
Received funding from VLAIO Team Business Trajectories.
For institutional investors. Book with your work email.
Aphea.Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aphea.Bio's valuation, stock price, and market status.
Is Aphea.Bio a public or private company?
Aphea.Bio is a private company.
What is the current stock price of Aphea.Bio?
Aphea.Bio is a private company, so its shares have no public market price. Caplight tracks Aphea.Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aphea.Bio worth (valuation)?
Valuation information for Aphea.Bio is not publicly available.
Can I buy Aphea.Bio stock?
Aphea.Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aphea.Bio's last funding round?
Aphea.Bio's most recent funding round was Grant on September 16, 2025.
Who are the main investors in Aphea.Bio?
Key investors in Aphea.Bio include Astanor Ventures, V-Bio Ventures, VLAIO, Innovation Industries, ECBF Management.
Will Aphea.Bio IPO soon?
No public IPO plans have been announced for Aphea.Bio.
How can I track Aphea.Bio secondary market activity?
Caplight tracks bids, offers, and trades in Aphea.Bio's shares on secondary markets.